Azione IVCP SWIFTMERGE ACQUISITION CORP.
Aggiungi a un elenco
Solo clienti o iscritti possono usare questa funzione
AccediRegistrati

Altre lingue Swiftmerge Acquisition Corp.

Azioni

IVCP

KYG638361033

Mercato chiuso - Nasdaq
Altri mercati azionari
 22:30:01 10/07/2024 		Variaz. 5gg Var. 1 gen.
10,99 USD +0,09% Grafico intraday di Swiftmerge Acquisition Corp. +0,09% +1,10%
20/05 Swiftmerge Acquisition Corp. Riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024 CI
01/04 Swiftmerge Acquisition Corp. Riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023 CI

Altre lingue

Ricerca
Vedi i risultati
Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!
Registrazione 100% gratuita
Swiftmerge Acquisition : AleAnna, A Next Generation European Natural Gas Company, Signs Agreement to be Publicly Listed Through Combination with Swiftmerge Acquisition Corp Form 8 K
AleAnna Energy, LLC agreed to acquire Swiftmerge Acquisition Corp. in a reverse merger transaction for approximately $710 million.
Swiftmerge Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024
Swiftmerge Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
Swiftmerge Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Swiftmerge Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Swiftmerge Acquisition : Non-Reliance on Previously Issued Financial Statements or Related Audit Report or Completed Interim Report - Form 8-K
Swiftmerge Acquisition Signs Merger Deal to Take HDL Therapeutics Public
HDL Therapeutics to Go Public in Merger with Swiftmerge Acquisition Corp.
SWIFTMERGE ACQUISITION CORP. : Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
Swiftmerge Acquisition : Adjournment of Extraordinary General Meeting - Form 8-K
Swiftmerge Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
SWIFTMERGE ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
HDL Therapeutics Inc Plans to Become Publicly Traded via a Business Combination With $225 Million Swiftmerge (NASDAQ: IVCP) With Goal to Transform Cardiovascular Disease Treatment
HDL Therapeutics, Inc. signed a non-binding letter of intent to acquire Swiftmerge Acquisition Corp. in a reverse merger transaction.
SWIFTMERGE ACQUISITION CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
SWIFTMERGE ACQUISITION CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Swiftmerge Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
Swiftmerge Acquisition Corp. Auditor Raises 'Going Concern' Doubt
Swiftmerge Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Non ci sono risultati per questa ricerca
Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Cerca

Data di pubblicazione

Da

A

  1. Borsa valori
  2. Azioni
  3. Azione IVCP
  4. Notizie Swiftmerge Acquisition Corp.
  5. Altre lingue